Plain-English translation of NCT06463912 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at how common hepatitis C is among people who inject drugs in the city of Armenia, Colombia. Researchers will use a simple blood test to screen for hepatitis C antibodies, and if you test positive, they will confirm the result with an additional test and help connect you with treatment options.
Hepatitis C is a serious liver infection that can be treated, but many people who inject drugs don't know they have it or can't access care. This study aims to find out how many people in Armenia are affected and to help them get diagnosed and linked to treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you would come in for a visit where researchers will take a small blood sample using a rapid hepatitis C antibody test. You will also complete a brief survey about your health and background. If your rapid test is positive, you'll have a follow-up blood test to confirm the results. Throughout the process, the study team will help connect you with treatment and care resources.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Colombia
Enrollment target
~205 participants
Started
May 2024
Primary completion
January 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Javier Hernández Blanco, MD
Asociación Colombiana de Hepatología
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.